Equities

Cencosud SA

CENCOSUD:SGO

Cencosud SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CLP)1,936.60
  • Today's Change-30.40 / -1.55%
  • Shares traded976.53k
  • 1 Year change+30.41%
  • Beta0.8088
Data delayed at least 20 minutes, as of Nov 08 2024 19:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CLPIncome statement in CLPView more

Year on year Cencosud SA's net income fell -35.01% from 338.93bn to 220.28bn despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 19.73% to 21.30%.
Gross margin29.38%
Net profit margin2.04%
Operating margin7.10%
Return on assets2.17%
Return on equity5.48%
Return on investment3.17%
More ▼

Cash flow in CLPView more

In 2023, Cencosud SA increased its cash reserves by 29.28%, or 109.43bn. The company earned 1.45tn from its operations for a Cash Flow Margin of 10.17%. In addition the company used 313.44bn on investing activities and also paid 994.93bn in financing cash flows.
Cash flow per share267.84
Price/Cash flow per share7.12
Book value per share1,534.38
Tangible book value per share595.68
More ▼

Balance sheet in CLPView more

Cencosud SA has a Debt to Total Capital ratio of 51.83%, a lower figure than the previous year's 114.87%.
Current ratio0.8654
Quick ratio0.4293
Total debt/total equity1.23
Total debt/total capital0.5183
More ▼

Growth rates in CLP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -18.90% and -35.22%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)9.12%
Div growth rate (5 year)32.73%
Payout ratio (TTM)26.07%
EPS growth(5 years)2.88
EPS (TTM) vs
TTM 1 year ago
-19.27
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.